Viewing Study NCT03819660


Ignite Creation Date: 2025-12-25 @ 2:06 AM
Ignite Modification Date: 2026-05-18 @ 7:02 PM
Study NCT ID: NCT03819660
Status: TERMINATED
Last Update Posted: 2023-11-30
First Post: 2019-01-23
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Long Term Safety of Amifampridine Phosphate in Spinal Muscular Atrophy 3
Sponsor: Catalyst Pharmaceuticals, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: SMA-002
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators